Yi Xia

4.2k citations

165 papers · 2.5k indexed · h-index 29

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Genetics top 2%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Pathology and Forensic Medicine 116
- Lymphoma Diagnosis and Treatment 114
Oncology 76
- Viral-associated cancers and disorders 46
- CAR-T cell therapy research 9

Co-authors: Zhiming Li (34 shared papers)Panpan Liu (36 shared papers)Yu Wang (20 shared papers)Wei Xu (59 shared papers)Peng Sun (18 shared papers)Wen-Qi Jiang (26 shared papers)Jianyong Li (53 shared papers)Lei Fan (53 shared papers)
Journals: Annals of Hematology (14 papers)Blood (11 papers)Leukemia Research (8 papers)Oncotarget (7 papers)Chinese Journal of Cancer (6 papers)
Partner nations: China United States Netherlands

In The Last Decade

Yi Xia

158 papers receiving 2.5k citations

Peers

Countries citing papers authored by Yi Xia

Since Specialization

Citations

This map shows the geographic impact of Yi Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xia more than expected).

Fields of papers citing papers by Yi Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xia. The network helps show where Yi Xia may publish in the future.

Co-authors

The 25 scholars most cited alongside Yi Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi Xia Line = papers co-authored together Yi Xia links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling Clinical Cancer Research ·Man Nie, Linbin Yang, Xiwen Bi, Yu Wang, Peng Sun, Hang Yang, Panpan Liu, Zhiming Li, Yi Xia, Wenqi Jiang	2018	206
2	Hsa‐mir‐27a genetic variant contributes to gastric cancer susceptibility through affecting miR‐27a and target gene expression Cancer Science ·Qingmin Sun, Haijuan Gu, Ying Zeng, Yi Xia, You Wang, Yali Jing, Li Yang, Bin Wang	2010	142
3	Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP PLoS ONE ·Zhiming Li, Jia-Jia Huang, Yi Xia, Jian Sun, Ying Huang, Yu Wang, Ying-Jie Zhu, Ya-Jun Li, Wei Zhao, Wen-Xiao Wei, Tong-Yu Lin, Hui-Qiang Huang, Wen-Qi Jiang	2012	127
4	High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma Medical Oncology ·Qi-Chun Cai, Hong Liao, Su-Xia Lin, Yi Xia, Xiao-xaio Wang, Yan Gao, Ze-Xiao Lin, Jia-Bin Lu, Hui-Qiang Huang	2011	71
5	Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Yi Xia, L. Jeffrey Medeiros, Ken H. Young	2015	56
6	Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma Signal Transduction and Targeted Therapy ·Jun Cai, Panpan Liu, Huiqiang Huang, Yajun Li, Shu‐Yun Ma, Hui Zhou, Xiao‐Peng Tian, Yuchen Zhang, Yan Gao, Yi Xia, Xuanye Zhang, Hang Yang, Lirong Li, Qingqing Cai	2020	53
7	High Ki‐67 expression in diffuse large B‐cell lymphoma patients with non‐germinal center subtype indicates limited survival benefit from R‐CHOP therapy European Journal Of Haematology ·Zhiming Li, Jiajia Huang, Yi Xia, Yingjie Zhu, Wei Zhao, Wen‐Xiao Wei, Wenqi Jiang, Tongyu Lin, Huiqiang Huang, Zhong‐Zhen Guan	2012	49
8	Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis Aging ·Wei Wu, Zijuan Wu, Yi Xia, Shuchao Qin, Yue Li, Jia‐Zhu Wu, Jin‐Hua Liang, Li Wang, Huayuan Zhu, Lei Fan, Jianxin Fu, Wei Xu, Hui Jin, Jianyong Li	2019	44
9	The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma Hematological Oncology ·Yixin Zou, Huayuan Zhu, Xiao‐Tong Li, Yi Xia, Kourong Miao, Si‐Shu Zhao, Yujie Wu, Li Wang, Wei Xu, Jianyong Li	2019	43
10	Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans Oncotarget ·Yi Xia, Lei Fan, Li Wang, Robert Peter Gale, Man Wang, Tian Tian, Wei Wu, Liang Yu, Yao-Yu Chen, Wei Xu, Jianyong Li	2014	42
11	Tetraspanin CD37 protects against the development of B cell lymphoma Journal of Clinical Investigation ·Charlotte M. de Winde, Sharon Veenbergen, Ken H. Young, Zijun Y. Xu‐Monette, Xiao-Xiao Wang, Yi Xia, Kausar J. Jabbar, Michiel van den Brand, Alie van der Schaaf, Suraya Elfrink, Inge S. van Houdt, Marion J. Gijbels, Fons A. J. van de Loo, Miranda B. Bennink, Konnie M. Hebeda, Patricia J.T.A. Groenen, J. Han van Krieken, Carl G. Figdor, Annemiek B. van Spriel	2016	41
12	Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type PLoS ONE ·Ya-Jun Li, Zhiming Li, Yi Xia, Jia-Jia Huang, Hui-Qiang Huang, Zhong-Jun Xia, Tong-Yu Lin, Li Su, Xiu-Yu Cai, Zhi-jun Wu-Xiao, Wen-Qi Jiang	2013	41
13	Pathogenic Gene Mutations or Variants Identified by Targeted Gene Sequencing in Adults With Hemophagocytic Lymphohistiocytosis Frontiers in Immunology ·Yi Miao, Huayuan Zhu, Chun Qiao, Yi Xia, Yi-Ling Kong, Yixin Zou, Yuqing Miao, Chen Xiao, Lei Cao, Wei Wu, Jin‐Hua Liang, Jia‐Zhu Wu, Li Wang, Lei Fan, Wei Xu, Jianyong Li	2019	40
14	Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial The Lancet Haematology ·Qiudan Shen, Huayuan Zhu, Li Wang, Lei Fan, Jin‐Hua Liang, Lei Cao, Wei Wu, Yi Xia, Jianyong Li, Wei Xu	2018	40
15	Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma Journal of Cancer ·Man Nie, Peng Sun, Cui Chen, Xiwen Bi, Yu Wang, Hang Yang, Panpan Liu, Zhiming Li, Yi Xia, Wenqi Jiang	2017	38
16	Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma BMC Cancer ·Jia-Jia Huang, Ya Jun Li, Yi Xia, Yu Wang, Wen Wei, Ying-Jie Zhu, Tong-Yu Lin, Hui-Qiang Huang, Wen-Qi Jiang, Zhi-Ming Li	2013	37
17	The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma Disease Markers ·Peng Sun, Cui Chen, Yi Xia, Xiwen Bi, Panpan Liu, Fei Zhang, Hang Yang, Xin An, Wenqi Jiang, Feng‐Hua Wang	2017	36
18	Immune checkpoint blockade: Releasing the brake towards hematological malignancies Blood Reviews ·Yi Xia, L. Jeffrey Medeiros, Ken H. Young	2015	35
19	Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression Leukemia & lymphoma ·Xin Cao, L. Jeffrey Medeiros, Yi Xia, Xiaoxiao Wang, Sheeba K. Thomas, Sanam Loghavi, Xin Li, Jatin J. Shah, Steven A. Gustafson, Donna M. Weber, Roberto N. Miranda, Zijun Y. Xu‐Monette, Robert Z. Orlowski, Ken H. Young	2015	35
20	Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma Annals of Hematology ·Xi-Wen Bi, Yi Xia, Wen-wen Zhang, Peng Sun, Panpan Liu, Yu Wang, Jia-Jia Huang, Wen-Qi Jiang, Zhiming Li	2015	34

About Yi Xia

Yi Xia is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Molecular Biology, having authored 165 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (114 papers), Chronic Lymphocytic Leukemia Research (51 papers), Viral-associated cancers and disorders (46 papers), Immune Cell Function and Interaction (22 papers), CNS Lymphoma Diagnosis and Treatment (18 papers), Immunodeficiency and Autoimmune Disorders (15 papers), CAR-T cell therapy research (9 papers) and Acute Myeloid Leukemia Research (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Genetics (505 citations), Oncology (1.1k citations), Immunology (760 citations) and Cancer Research (379 citations). Yi Xia has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhiming Li, Panpan Liu, Yu Wang, Wei Xu, Peng Sun, Wen-Qi Jiang, Jianyong Li, Lei Fan, Huayuan Zhu and Hui-Qiang Huang. Their work appears in journals such as Annals of Hematology, Blood, Leukemia Research, Oncotarget and Chinese Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact